Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Mohammad R. Parwaresch"'
Autor:
Ira Van Ophemert, Heinz-Joachim Radzun, Mohammad R. Parwaresch, Hans-Heinrich Wacker, Frank Zschunke, Peter Middel, Barbro Wynne Patterson
Publikováno v:
Cell and Tissue Research. 307:347-355
Human sinus-lining cells (SLC) of the lymph node sinuses most probably represent accessory cells for the primary humoral immune response and have been shown to express a unique antigen recognized by the monoclonal antibody Ki-M9. To characterize this
Autor:
Korbjuhn P, Markus Tiemann, Ioannis Anagnostopoulos, Mohammad R. Parwaresch, Harald Stein, Michael Hummel
Publikováno v:
Histopathology. 25:331-337
This study deals with the investigation of the biological significance of an Epstein-Barr virus (EBV) infection in lymphoepithelioid cell lymphoma. A selection of EBV-detection techniques was applied to 15 cases, including polymerase chain reaction (
Publikováno v:
Histopathology. 21:439-446
Lymph nodes from 21 cases of generalized mastocytosis were studied histologically to confirm or exclude mast cell infiltration, and to investigate their micro-architecture. Mast cell infiltrates were detected in 17 (80%) of the lymph nodes and were f
Autor:
Bharat N. Nathwani, M.-L. Hansmann, Mohammad R. Parwaresch, Hans Heinrich Wacker, Heinz J. Radzun, Masahiro Kikuchi, Kristina Hesse
Publikováno v:
Human Pathology. 23:676-680
The new monoclonal antibody Ki-M1P, which detects a formalin-resistant epitope on conventional paraffin sections, was applied in 20 cases of different stages of Kikuchi-Fujimoto disease. This new pan-macrophage immunoreagent detects plasmacytoid T ce
Publikováno v:
The Journal of Pathology. 166:113-119
Although the immunological response during infectious mononucleosis (IMN) has been studied in detail, little is known about the spread of Epstein-Barr virus (EBV) in lymphoid organs or the topographical distribution of the infected cells. In this stu
Publikováno v:
Leukemia & Lymphoma. 8:459-464
Agnogenic myeloid metaplasia (AMM) is a chronic myeloproliferative disorder that leads to a sustained proliferation of megakaryocytes and an increase of reticulin fibers within the bone marrow. Blood and bone marrow samples from patients with advance
Publikováno v:
Research in Immunology. 143:125-128
Human monocyte serine esterase 1 (HMSE1) was purified from U937 cell extract. Since the N terminus of the enzyme was blocked, cleavage with trypsin was used to obtain several peptides accessible to amino acid sequencing. Based on partial amino acid s
Autor:
Hans Heinrich Wacker, Hans J. Heidebrecht, H. J. Radzun, Mohammad R. Parwaresch, Heike Lumbeck, M. L. Hansmann, Jörn Gralla, Markus Kossmahl
Publikováno v:
Blood. 77:809-817
In the search for immunoreagents appropriate for the histopathologic diagnosis of malignant B-cell lymphomas in routinely processed paraffin sections, a new monoclonal antibody, Ki-B5, was generated using a high- grade B-cell lymphoma as the immunoge
Six new monoclonal antibodies to serous, mucinous, and poorly differentiated ovarian adenocarcinomas
Publikováno v:
Cancer. 65:1525-1532
Six monoclonal antibodies directed against ovarian adenocarcinoma were generated by use of 100,000 x g supernatants of Triton-X-100 solubilized extracts of ovarian serous adenocarcinoma as the antigen source. Immunoperoxidase preparation of frozen-se
Autor:
D. Gerhartz, A.R. Haunauske, C. Schadeck-Gressel, R. Fuchs, Christian Peschel, B. Geiseler, Andreas Engert, Karl Lennert, R. Brandmaier, W. Spann, P. Meusers, P. Müller, Mohammad R. Parwaresch, Eckhard Thiel, Wolf-Dieter Ludwig, H. Radtke, H. H. Gerhartz, Wolfgang Wilmanns, L. Färber, H.J. Ehrlich, H.W. Pees, Günter Brittinger, H.-J. Hartlapp, M. Engelhard, Markus Tiemann, E. Terhardt, Dieter Huhn, G. Schlimok, Wolfgang Siegert
Publikováno v:
Annals of Oncology. 5:S123-S125
Summary In high-grade malignant non-Hodgkin's lymphomas (hNHL) recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) was evaluated as support to chemotherapy. In a phase III trial, 172 patients (age 18–73 years, stage II-IV)